RICE HALL JAMES & ASSOCIATES, LLC - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 114 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
RICE HALL JAMES & ASSOCIATES, LLC ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$19,513,000
+1.8%
369,359
+18.1%
0.79%
-4.5%
Q2 2020$19,164,000
+5.2%
312,725
-2.9%
0.82%
-19.2%
Q1 2020$18,215,000
-8.2%
321,994
-7.6%
1.02%
+51.7%
Q4 2019$19,841,000
+5.8%
348,462
-0.5%
0.67%
+0.1%
Q3 2019$18,746,000
-11.4%
350,268
-1.2%
0.67%
-4.7%
Q2 2019$21,165,000
+7.5%
354,455
+12.2%
0.70%
+10.9%
Q1 2019$19,695,000
+29.3%
315,972
+25.7%
0.63%
+14.2%
Q4 2018$15,228,000
+43.3%
251,281
+38.3%
0.56%
+46.1%
Q3 2018$10,627,000
+16.0%
181,690
-11.0%
0.38%
+14.1%
Q2 2018$9,160,000
+27.7%
204,183
+26.2%
0.33%
+18.9%
Q1 2018$7,172,000
+6.6%
161,754
+4.1%
0.28%
+5.7%
Q4 2017$6,730,000
-7.4%
155,318
-0.5%
0.26%
-17.4%
Q3 2017$7,265,000
-9.2%
156,167
-3.4%
0.32%
-7.8%
Q2 2017$8,004,000
+11.9%
161,671
+23.9%
0.35%0.0%
Q1 2017$7,151,000
-2.7%
130,496
-1.2%
0.35%
-6.2%
Q4 2016$7,353,000
+19.6%
132,015
-1.9%
0.37%
+15.6%
Q3 2016$6,147,000
+27.2%
134,590
+11.2%
0.32%
+15.5%
Q2 2016$4,833,000
+22.6%
121,002
+6.8%
0.28%
+21.9%
Q1 2016$3,943,000
+17.1%
113,247
+44.6%
0.23%
+18.8%
Q4 2015$3,366,000
+51.6%
78,332
+53.6%
0.19%
+33.3%
Q3 2015$2,221,000
-16.4%
51,003
-0.9%
0.14%
-5.9%
Q2 2015$2,656,000
+15.7%
51,473
-12.2%
0.15%
+15.0%
Q1 2015$2,295,000
+202.8%
58,623
+198.8%
0.13%
+189.1%
Q4 2014$758,000
-3.4%
19,620
-11.7%
0.05%
-16.4%
Q3 2014$785,000
+4.8%
22,226
-20.0%
0.06%
+10.0%
Q2 2014$749,000
+27.8%
27,774
+22.9%
0.05%
+16.3%
Q1 2014$586,000
+24.7%
22,599
+4.1%
0.04%
+26.5%
Q4 2013$470,00021,7050.03%
Other shareholders

There were no reported owners of BIOSPECIFICS TECHNOLOGIES CO in Q3 2020.

NameSharesValueWeighting ↓
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders